Tracheobronchial manifestations of Aspergillus infections

Rafal Krenke1, Elzbieta M Grabczak

  • 1Department of Internal Medicine, Pneumonology and Allergology, Medical University of Warsaw, 02-097 Warsaw, Poland. rkrenke@wum.edu.pl

Thescientificworldjournal
|December 24, 2011
PubMed

Insights

Aspergillus spores can cause lung infections, particularly in immunocompromised individuals. This review details invasive Aspergillus airway diseases in different patient groups, including transplant recipients and those with hematologic malignancies.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Mycology

Background:

  • Human lungs are exposed to Aspergillus spores daily.
  • While typically harmless to healthy individuals, these spores can cause disease in those with weakened immune systems.
  • Tracheobronchial aspergillosis, an infection of the airways, can manifest as saprophytic, allergic, or invasive disease.

Purpose of the Study:

  • To review the spectrum of tracheobronchial aspergillosis.
  • To focus on invasive Aspergillus airway infections.
  • To differentiate clinical courses and prognoses based on predisposing conditions.

Main Methods:

  • Review of existing literature on tracheobronchial aspergillosis.
  • Categorization of invasive Aspergillus airway diseases by patient risk groups.
  • Discussion of clinical presentation, course, and prognosis within these groups.

Main Results:

  • Invasive Aspergillus tracheobronchial infections present differently across patient populations.
  • Risk factors significantly influence the clinical course and outcomes.
  • Three main patient groups are identified: lung transplant recipients, highly immunocompromised patients (hematologic malignancies/stem cell transplant), and less immunocompromised/immunocompetent individuals.

Conclusions:

  • Understanding the specific patient context is crucial for managing invasive Aspergillus airway infections.
  • Prognosis varies significantly based on the degree of immune compromise and underlying condition.
  • Comprehensive management requires tailored approaches for different risk groups.

Related Concept Videos

Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
The Bronchial Tree01:23

The Bronchial Tree

The human bronchi and bronchial tree play a crucial role in the respiratory system, facilitating the exchange of oxygen and carbon dioxide. Let's delve into the intricate structure and functions of these respiratory components.
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...